Pharmacy stock loans

Financial support for pharmacists

Why get a pharmacy stock loan from Wesleyan Bank?

The COVID-19 pandemic has put pharmacies under more pressure than ever, with rising costs a threat to your cashflow. A stock loan can be a real shot in the arm for your finances.

  • Loans available for sums over £5,000 
  • Pay suppliers up front, and spread your repayments for up to 5 years
  • Meet increasing demand for medication while protecting your cashflow
  • Get the support of a dedicated account manager

How it works

Running a pharmacy has never been easy - but the impacts of COVID-19 have made things even tougher. With medication costs increasing and some suppliers changing their terms to request payment up front, many pharmacies are struggling to meet demand.

It leaves you with a difficult decision. Either your cashflow takes a dip, or your stock levels do. But with a pharmacy stock loan from Wesleyan Bank, it’s not a choice you have to make. 

We can provide the funds you need to pay your suppliers, and you simply pay us back through manageable monthly payments.

Why Wesleyan Bank?

We’ve been working with the healthcare sector for decades, so we understand the challenges you face as a pharmacist.

Our knowledge of your sector means we can be more flexible than most lenders when assessing your application.

How we help

When you apply for funding, you’ll be supported by a dedicated healthcare manager every step of the way. But stock loans aren’t the only way we can support your business. 

We can also provide acquisition finance, funding for new technologies like robotic dispensers, or simply help you spread the cost of your tax bills.

Important information

Wesleyan Bank acts as a broker and a lender.

Written quotations are available on request from Wesleyan Bank Ltd. Credit facilities are subject to status and only available to UK residents over the age of 18. Wesleyan Bank Ltd reserves the right to decline any application.

Depending on the circumstances and where required by law, loans will be regulated by the Financial Conduct Authority and the Consumer Credit Act.